Title:
PHARMACEUTICAL COMPOSITION CONTAINING CYCLOALKYL UREA DERIVATIVE
Document Type and Number:
Japanese Patent JP2022183120
Kind Code:
A
Abstract:
To provide an agent for treating or preventing diseases associated with an orexin receptor, particularly an orexin 2 receptor.SOLUTION: This invention relates to an agent for treating or preventing diseases such as narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, the agent containing a novel compound having a urea skeleton represented by formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient.SELECTED DRAWING: None
More Like This:
| JP2006225388 | PIPERAZINE DERIVATIVE |
| JP2010505803 | Manufacture of rimcazole |
| JP2015025014 | 2-AMINOPYRIDINE DERIVATIVES USEFUL AS KINASE INHIBITORS |
Inventors:
IDEGAMI EIJI
KOMIYA MASABUMI
RI KANEMITSU
UESUGI JUNICHIRO
FUNAKOSHI YUTA
KOMIYA MASABUMI
RI KANEMITSU
UESUGI JUNICHIRO
FUNAKOSHI YUTA
Application Number:
JP2022086267A
Publication Date:
December 08, 2022
Filing Date:
May 26, 2022
Export Citation:
Assignee:
SUMITOMO DAINIPPON PHARMA CO LTD
International Classes:
A61K31/496; A61K31/454; A61K31/4545; A61K31/46; A61K31/495; A61K31/4995; A61K31/506; A61K31/55; A61K31/551; A61P1/02; A61P1/04; A61P1/08; A61P1/16; A61P3/04; A61P3/06; A61P3/10; A61P5/06; A61P9/00; A61P9/02; A61P9/04; A61P9/06; A61P9/10; A61P9/12; A61P11/00; A61P13/00; A61P15/00; A61P15/08; A61P19/02; A61P19/06; A61P21/00; A61P21/04; A61P25/00; A61P25/04; A61P25/06; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/24; A61P25/26; A61P25/28; A61P25/30; A61P27/02; A61P27/16; A61P29/00; A61P35/00; A61P35/02; A61P43/00
Attorney, Agent or Firm:
Yamato Kento
Shinagawa
Wu Yingyan
Masahiro Suwon
Shinagawa
Wu Yingyan
Masahiro Suwon
Previous Patent: A device for holding a bag, a bag, and a method for attaching the bag
Next Patent: Spectral time modulation detection test unit
Next Patent: Spectral time modulation detection test unit